# University of Pennsylvania: Not applicable (device, behavioral) study completed, 603 enrolled (Psoriasis, Psoriatic Arthritis)

**Score:** 65/100

| Field | Value |
|---|---|
| Sponsor | University of Pennsylvania |
| Sponsor type | Academic and hospital |
| Study | Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis |
| NCT ID | NCT05908240 |
| Phase | Not applicable (device, behavioral) |
| Status | completed |
| Conditions | Psoriasis; Psoriatic Arthritis; Psoriatic Conditions; Cardiovascular Diseases |
| Intervention types | other |
| Target enrollment | 603 |
| Site countries | United States |
| Posted | 2023-06-18 |
| Planned start | 2023-06-15 |
| Event | Completed |
| Event date | 2026-10-16 |
| Last update posted | 2026-10-29 |

## Why this score
- Posted in the last two weeks.
- Completed: closeout, analysis and the next study ahead.
- 603 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT05908240). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.